JNJ Johnson & Johnson
Healthcare$230.18-1.78%ClosedMarket Cap: $554.09B
As of 2026-05-26
Valuation
P/E (TTM)
21.44
PEG
0.24
P/B
7.06
P/S
5.85
EV/EBITDA
17.71
DCF Value
$319.62
FCF Yield
3.2%
Div Yield
2.2%
Margins & Returns
Gross Margin
69.1%
Operating Margin
26.9%
Net Margin
21.8%
ROE
26.3%
ROA
10.5%
ROIC
13.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $24.06B | 71.5% | $6.39B | $5.24B | $— | $1.30 |
| Q1 null | $24.06B | 71.5% | $6.39B | $5.24B | $— | $1.30 |
| Q4 null | $24.56B | 67.6% | $5.59B | $5.12B | $— | $1.30 |
| FY null | $94.19B | 72.8% | $25.60B | $26.80B | $— | $5.14 |
| Q3 null | $23.99B | 69.6% | $7.10B | $5.15B | $— | $1.30 |
| Q2 null | $23.74B | 67.9% | $6.81B | $5.54B | $— | $1.30 |
| Q1 null | $21.89B | 66.4% | $6.30B | $11.00B | $— | $1.24 |
| Q4 null | $22.52B | 68.3% | $3.84B | $3.43B | $— | $1.24 |
| FY null | $88.82B | 69.1% | $22.15B | $14.07B | $— | $4.91 |
| Q3 null | $22.47B | 69.0% | $5.28B | $2.69B | $— | $1.24 |
| Q2 null | $22.45B | 69.4% | $6.66B | $4.69B | $— | $1.24 |
| Q1 2024 | $21.38B | 69.6% | $6.27B | $3.25B | $1.34 | $1.19 |